We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial (201622)
ARTG ID 201622
ARTG Name
KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial
Product name
KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Trastuzumab emtansine
Licence category
RE
Licence status
A
Summary
Product information
Consumer medicine information